20 October 2021 Calym
RedTalks Season2 #2: PDX a powerful tool of n...
19 October 2021 Lysarc
Cell Therapy Innovation 360°
11 October 2021 Calym
CALYM’s active role in the research eco...
03 October 2021 Calym
With OncoSTARTUPPER, participate in the Oncol...
24 September 2021 Calym
RedTalks Season2 #1: A macro view of the tumo...
15 September 2021 Calym
Carnot CALYM Institute Interactive Activity R...
14 September 2021 Lysa
World Lymphoma Day 2021
08 September 2021 Lysa
LYSA Presentations at the 2021 SFH Congress
26 August 2021 Lysa
6th edition of LYSA days, Rennes 2021
01 June 2021 Lysa
LYSA presentations in June 2021 international...
31 May 2021 Calym
Launch of OncoSTART consortium supporting onc...
27 May 2021 Lysarc
Launch of BiCAR: an unprecedented clinical s...
18 May 2021 Calym
RedTalks #9 : Epigenetic Bases and Therapy Ly...
27 April 2021 Lysarc
2000th patient included in REALYSA – th...
On April 22, 2021, at the University Hospital Center of Lyon Sud, was recru...
24 March 2021 Lysa
The LYSA/LYSARC launches the first french aca...
19 March 2021 Calym
RedTalks #7: From 2 Cancer Centers to Industr...
09 March 2021 Calym
CALYM consortium, and SideROS are launching a...
02 March 2021 Calym
Partnership agreement between the Carnot CALY...
24 February 2021 Lysarc
Press release – Daiichi Sankyo and LYSA...
09 February 2021 Calym
A new framework agreement for CALYM
04 February 2021 Calym
RedTalks #6: Understanding T-cell lymphoma
18 January 2021 Calym
RedTalks #5: CD19 CAR T cells for B-cell NHL ...
07 January 2021 Lysa
COVID vaccination: LYSA recommendations
The LYSA Group totally recommends vaccination against COVID for patients wi...
01 January 2021 Lysarc
Happy New Year 2021